Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Sobrino-Fernandez, E; Campos-Dominguez, M; Gregorio-Hernandez, R; Huerta-Aragones, J; Belendez-Bieler, C; Lancharro-Zapata, A; Franco-Fernandez, ML; Bernardo-Atienza, B; Sanchez-Luna, M.

Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis

PEDIATRIC DERMATOLOGY. 2017; 34(3): 128-129 Nº de citas: 5 [doi:10.1111/pde.13101]

Cayrol, J; Colino, CG.

Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2017; 39(4): 187-190 Nº de citas: 6 [doi:10.1097/MPH.0000000000000785]

Vazquez, L; Salavert, M; Gayoso, J; Lizasoain, M; Camps, IR; Di Benedetto, N; Study Grp Risk Factors IFI Using.

Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2017; 30(2): 103-117 Nº de citas: 6

Bardon-Cancho, EJ; Haro-Diaz, A; Alonso-Garcia-de la Rosa, F; Huerta-Aragones, J; Garcia-Morin, M; Gonzalez-Martinez, F; Garrido-Colino, C.

DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations

FAMILIAL CANCER. 2017; 16(2): 291-294 Nº de citas: 9 [doi:10.1007/s10689-016-9949-6]

Garcia-Montoya, L; Saenz-Tenorio, CN; Janta, I; Menarguez, J; Lopez-Longo, FJ; Monteagudo, I; Naredo, E.

Hemophagocytic lymphohistiocytosis in a patient with Sjogren's syndrome: case report and review

RHEUMATOLOGY INTERNATIONAL. 2017; 37(4): 663-669 Nº de citas: 11 [doi:10.1007/s00296-016-3601-5]

Garcia-Gutierrez, V; Gomez-Casares, MT; Puerta, JM; Alonso-Dominguez, JM; Osorio, S; Hernandez-Boiuda, JC; Collado, R; Ramirez, MJ; Ibanez, F; Martin, ML; Rodriguez-Gambarte, JD; Martinez-Laperche, C; Gomez, M; Fiallo, DV; Redondo, S; Rodriguez, A; Ruiz-Nuno, C; Steegmann, JL; Jimenez-Velasco, A.

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia

PLoS One. 2017; 12(3): Nº de citas: 6 [doi:10.1371/journal.pone.0173532]

Morin, MG; Cela, E; Garrido, C; Cancho, EB; del Hoyo, AA; Pascual, C; Perez-Corral, A; Belendez, C.

Bone marrow transplant in patients with sickle cell anaemia. Experience in one centre

ANALES DE PEDIATRIA. 2017; 86(3): 142-150 Nº de citas: 8 [doi:10.1016/j.anpedi.2016.03.014]

Montalban, C; Diaz-Lopez, A; Dlouhy, I; Rovira, J; Lopez-Guillmermo, A; Alonso, S; Martin, A; Sancho, JM; Garcia, O; Sanchez, JM; Rodriguez, M; Novelli, S; Salar, A; Gutierrez, A; Rodriguez-Salazar, MJ; Bastos, M; Dominguez, JF; Fernandez, R; de Villambrosia, SG; Queizan, JEA; Cordoba, R; de Ona, R; Lopez-Hernandez, A; Freue, JM; Garrote, H; Lopez, L; Martin-Moreno, AM; Rodriguez, J; Abraira, V; Garcia, JF.

Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of beta(2)-microglobulin yields a more accurate GELTAMO-IPI

BRITISH JOURNAL OF HAEMATOLOGY. 2017; 176(6): 918-928 Nº de citas: 77 [doi:10.1111/bjh.14489]

Ruggeri, A; Sun, YQ; Labopin, M; Bacigalupo, A; Lorentino, F; Arcese, W; Santarone, S; Gulbas, Z; Blaise, D; Messina, G; Ghavamzadeh, A; Malard, F; Bruno, B; Diez-Martin, JL; Koc, Y; Ciceri, F; Mohty, M; Nagler, A.

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant

HAEMATOLOGICA. 2017; 102(2): 401-410 Nº de citas: 119 [doi:10.3324/haematol.2016.151779]

Reina-Castillon, J; Pujol, R; Lopez-Sanchez, M; Rodriguez-Santiago, B; Aza-Carmona, M; Gonzalez, JR; Casado, JA; Bueren, JA; Sevilla, J; Badel, I; Catala, A; Belendez, C; Dasi, MA; de Heredia, CD; Soulier, J; Schindler, D; Perez-Jurado, LA; Surralles, J.

Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia

Blood Advances. 2017; 1(5): 319-329 Nº de citas: 18 [doi:10.1182/bloodadvances.2016000943]

Rubio, MT; D'Aveni-Piney, M; Labopin, M; Hamladji, RM; Sanz, MA; Blaise, D; Ozdogu, H; Daguindeau, E; Richard, C; Santarone, S; Irrera, G; Yakoub-Agha, I; Yeshurun, M; Diez-Martin, JL; Mohty, M; Savani, BN; Nagler, A.

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

JOURNAL OF HEMATOLOGY & ONCOLOGY. 2017; 10: Nº de citas: 28 [doi:10.1186/s13045-016-0389-4]

Cervantes, F; Correa, JG; Perez, I; Garcia-Gutierrez, V; Redondo, S; Colomer, D; Jimenez-Velasco, A; Steegmann, JL; Sanchez-Guijo, F; Ferrer-Marin, F; Pereira, A; Osorio, S.

Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response

ANNALS OF HEMATOLOGY. 2017; 96(1): 81-85 Nº de citas: 25 [doi:10.1007/s00277-016-2839-z]

Martinez, C; Jorge, AS; Pereira, A; Moreno, M; Nunez, J; Gayoso, J; Gonzalez-Medina, J; Revilla, N; Sampol, A; Domingo-Domenech, E; de la Cruz, F; Morales, A; Rodriguez-Salazar, M; Valiente, S; Perez-Ceballos, E; de Oteyza, JP; Garcia-Sanz, R.

Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years

ANNALS OF HEMATOLOGY. 2017; 96(1): 9-16 Nº de citas: 14 [doi:10.1007/s00277-016-2832-6]

Cabrero, M; Martin, A; Briones, J; Gayoso, J; Jarque, I; Lopez, J; Grande, C; Heras, I; Arranz, R; Bernal, T; Perez-Lopez, E; Lopez-Godino, O; Conde, E; Caballero, D.

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2017; 23(1): 53-59 Nº de citas: 10 [doi:10.1016/j.bbmt.2016.10.003]

Marquez-Rodas, I; Lobo, M; Flores-Sanchez, C; Sanz, M; Luque, S; Lizarraga, S; Gonzalez-Asanza, C; Pajares, JA; Peligros, MI; Bueno, O; Mata, C; Lopez, C; Lopez-Tarruella, S; Jerez, Y; Munoz-Martin, A; Blanco, M; Die-Trill, M; Justel, JP; Solera, J; Martin, M.

Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital

ONCOLOGY. 2017; 92(2): 68-74 Nº de citas: 3 [doi:10.1159/000452280]

Cela, E; Velez, AG; Aguado, A; Medin, G; Bellon, JM; Belendez, C.

Chronic brain damage in sickle cell disease and its relation with quality of life

MEDICINA CLINICA. 2016; 147(12): 531-536 Nº de citas: 5 [doi:10.1016/j.medcli.2016.07.028]

Blanco, G; Puiggros, A; Baliakas, P; Athanasiadou, A; Garcia-Malo, M; Collado, R; Xochelli, A; Rodriguez-Rivera, M; Ortega, M; Calasanz, MJ; Luno, E; Vargas, M; Grau, J; Martinez-Laperche, C; Valiente, A; Cervera, J; Anagnostopoulos, A; Gimeno, E; Abella, E; Stalika, E; Hernandez-Rivas, JM; Ortuno, FJ; Robles, D; Ferrer, A; Ivars, D; Gonzalez, M; Bosch, F; Abrisqueta, P; Stamatopoulos, K; Espinet, B.

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

Oncotarget. 2016; 7(49): 80916-80924 Nº de citas: 23 [doi:10.18632/oncotarget.13106]

Ruiz Labarta, F. J.; Pintado Recarte, M. P.; Alvarez Luque, A.; Joigneau Prieto, L.; Perez Martin, L.; Gonzalez Leyte, M.; Palacio Abizanda, F.; Morillas Ramirez, F.; Perez Corral, A.; Ortiz Quintana, L.; De Leon-Luis, J..

Outcomes of pelvic arterial embolization in the management of postpartum haemorrhage: a case series study and systematic review

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 2016; 206: 12-21 Nº de citas: 24 [doi:10.1016/j.ejogrb.2016.07.510]